Rutherford Cross retained by Carcinotech to appoint Finance Manager

Carcinotech is a MedTech company based in Edinburgh, Scotland. They specialise in developing advanced 3D-printed living tumour models using patient-derived biopsies, primary cells, immune cells, and cancer stem cells. Their innovative models are designed for rapid, ethical, and accurate drug screening, pre-clinical testing, and personalised medicine.

Carcinotech was founded in 2018 since then, their innovation has already demonstrated significant impact. Supported by $2.05 million in seed funding and a major validation project with Cancer Research UK, the company is now enabling pharmaceutical and biotech companies to discover and test cancer drugs more efficiently. In early 2024, Carcinotech raised an additional $5.3 million to expand its operations in Edinburgh and enter the US market.

This is an excellent opportunity for a Newly Qualified candidate who has a forward-thinking mentality and is keen to work closely with the CFO across several key areas of the business. The successful candidate will oversee the financial operations, providing guidance and support to the Finance Assistant and supporting the CFO with annual budgeting, forecasting and cash flow.

Joining Carcinotech means you will be working with a business that is truly revolutionising and reinventing cancer research. Their vision is to be at the forefront of cancer drug testing and provide personalised medicine testing to each individual suffering from cancer to better their chance of treatment and survival.

For more information on the Finance Manager role, please view the Position Profile below.

Carcinotech – Finance Manager Position Profile Final